Impact of Microneedling on Coverage of RT1 Gingival Recession in Thin Phenotype.
Launched by POSTGRADUATE INSTITUTE OF DENTAL SCIENCES ROHTAK · May 22, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Gingival recession is defined as the migration of the marginal tissue toward the apical of the cementoenamel junction. It is one of the most common mucogingival deformities requiring surgical correction. The rationale for treating buccal recessions are mainly aesthetic concerns, and clinical situations where unfavourable contour of the gingival margin might be an obstacle for proper plaque control. Cairo et al in 2018 categorised GRs into 3 types with reference to interdental clinical attachment loss as RT1, RT2 and RT3. Mid-buccal GRs have root coverage potential through periodontal plasti...
Gender
ALL
Eligibility criteria
- INCLUSION CRITERIA:
- • Presence of isolated (RT1) by Cairo et al 2011 buccal maxillary gingival recessions in esthetic zone including maxillary central incisors, lateral incisors and canines associated with esthetic complaints and/or dental sensitivity and otherwise systemically healthy.
- • Gingival Recession ≥2mm and clinically identifiable CEJ
- • Age 20years-50 years
- • Patient demonstrating compliance for maintaining good oral hygiene after Phase 1 thearpy Plaque index (PI) \<1, Gingival Index (GI) \<1
- • Providing a written and verbal informed consent.
- • EXCLUSION CRITERIA
- • Patient with systemic disease that can influence the outcome of therapy.
- • Pregnant females or on oral contraceptive pills or hormone replacement therapy.
- • Smokers and patients undergoing orthodontic therapy
- • Physically and mentally impaired patients.
- • Non vital, malpositioned tooth
- • Presence of cervical abrasions or restorations in the area
- • Previous history of periodontal surgery on the involved sites.
Trial Officials
Amisha Goyal, BDS
Principal Investigator
PGIDS
About Postgraduate Institute Of Dental Sciences Rohtak
The Postgraduate Institute of Dental Sciences, Rohtak, is a premier academic institution dedicated to advancing dental education, research, and clinical practice. With a commitment to fostering innovation in oral health, the institute is actively engaged in conducting clinical trials that aim to enhance treatment methodologies and improve patient outcomes. By integrating cutting-edge research with comprehensive training, the institute plays a pivotal role in shaping the future of dental sciences, while adhering to the highest ethical standards and regulatory guidelines in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0